Pay in 4 interest-free payments of $6.11 Learn more
Ships within 48 hours Β· Estimated delivery Sep 3 - Sep 8
The firm pointed to the extensive gross-to-net adjustments that the manufacturers are already providing on these drugs. BMO Capital Markets, for its part, wrote in a note to investors, We reiterate that the important comparison remains the difference between the products newly discounted price and the products ultimate net price, including rebates, instead of their list prices
doi: 10.14309/00000434-201610001-00591 90 SehgalPSuSZechJNobelYLukLEconomouIet al
Novo also launched its Check Before You Inject campaign to educate patients on the risks associated with unregulated formulations
doi: 10.1038/s41392-023-01496-3, 6
The synergy rationale, and its status The pharmacological argument for combining these two is coherent on paper
